- Malignant Perivascular Epithelioid Cell Tumor (PEComa) of the Uterus as Part of the Hereditary Cancer Syndrome: A Case Diagnosed with Multiple Malignancies.
- Caliskan S, Akar OS, Gun S, Kefeli M.
- Turk Patoloji Derg. 2022 Dec 11. English. doi: 10.5146/tjpath.2022.01592. Epub ahead of print.
- PMID: 36367123
- PubMed abstract
- Case report
- Free Full Text
- A spectrum of BRCA1 and BRCA2 germline deleterious variants in ovarian cancer in Russia.
- Kechin A, Boyarskikh U, Barinov A, Tanas A, Kazakova S, Zhevlova A, Khrapov E, Subbotin S, Mishukova O, Kekeeva T, Demidova I, Filipenko M.
- Breast Cancer Res Treat. 2022 Nov 11. doi: 10.1007/s10549-022-06782-2. Epub ahead of print.
- PMID: 36367610
- PubMed abstract
- Source abstract
- Dr. Shore on the Importance of Genetic Testing in Prostate Cancer.
- Shore N.
- OncLive. 2022 Nov 11.
- Video
- Free video
- The prevalence of gene mutations in homologous recombination repair pathways in Japanese patients with metastatic castration-resistant prostate cancer in real-world clinical practice: The multi-institutional observational ZENSHIN study.
- Uemura H, Oya M, Kamoto T, Sugimoto M, Shinozaki K, Morita K, Koto R, Takahashi M, Nii M, Shin E, Nonomura N.
- Cancer Med. 2022 Nov 10. doi: 10.1002/cam4.5333. Epub ahead of print.
- PMID: 36358026
- PubMed abstract
- PARP Maintenance Therapy Provides Varying Benefit in Advanced Ovarian Cancer.
- Doherty K, Miller EM.
- OncLive. 2022 Nov 10.
- Optimizing Therapy for Ovarian Cancer: Recent Data Highlights - Episode 12: Investigative Therapies in Recurrent Ovarian Cancer.
- Monk BJ, Coleman RL, Westin SN, Birrer MJ.
- OncLive. Peer Exchange. 2022 Nov 10.
- Video
- Free video
- Molecular Management of High-Grade Serous Ovarian Carcinoma.
- Punzón-Jiménez P, Lago V, Domingo S, Simón C, Mas A.
- Int J Mol Sci. 2022 Nov 9;23(22):13777. doi: 10.3390/ijms232213777.
- Review
- Free Full Text
- Survival and Chemosensitivity in Advanced High Grade Serous Epithelial Ovarian Cancer Patients with and without a BRCA Germline Mutation: More Evidence for Shifting the Paradigm towards Complete Surgical Cytoreduction.
- De Jong D, Otify M, Chen I, Jackson D, Jayasinghe K, Nugent D, Thangavelu A, Theophilou G, Laios A.
- Medicina (Kaunas). 2022 Nov 8;58(11):1611. doi: 10.3390/medicina58111611.
- PMID: 36363568
- PubMed abstract
- Source abstract
- Canonical and uncanonical pathogenic germline variants in colorectal cancer patients by next-generation sequencing in a European referral center.
- Poliani L, Greco L, Barile M, Buono AD, Bianchi P, Basso G, Giatti V, Genuardi M, Malesci A, Laghi L; Alliance Against Cancer.
- ESMO Open. 2022 Nov 7;7(6):100607. doi: 10.1016/j.esmoop.2022.100607. Epub ahead of print.
- PMID: 36356413
- PubMed abstract
- Desire for Children and Distress in Women with Hereditary Cancer Syndromes.
- Kastner AM, Kocak HK, Fischer-Jacobs J, Hahne A, Zimmermann T.
- Int J Environ Res Public Health. 2022 Nov 4;19(21):14517. doi: 10.3390/ijerph192114517.
- PMID: 36361396
- PubMed abstract
- Source abstract
- Use of Breast Cancer Risk Factors to Identify Risk-Adapted Starting Age of Screening in China.
- Zheng Y, Dong X, Li J, Qin C, Xu Y, Wang F, Cao W, Xia C, Yu Y, Zhao L, Wu Z, Luo Z, Chen W, Li N, He J.
- JAMA Netw Open. 2022 Nov 1;5(11):e2241441. doi: 10.1001/jamanetworkopen.2022.41441.
- PMID: 36355372
- PubMed abstract
•• Commentary:
Risk-Based Approaches to Breast Cancer Screening in China.
- PMID: 36355377
- PubMed abstract
- Free Full Text
- MARGINAL: An Automatic Classification of Variants in BRCA1 and BRCA2 Genes Using a Machine Learning Model.
- Karalidou V, Kalfakakou D, Papathanasiou A, Fostira F, Matsopoulos GK.
- Biomolecules. 2022 Oct 24;12(11):1552. doi: 10.3390/biom12111552.
- PMID: 36358902
- PubMed abstract
- Source abstract